# AXIS Clinicals Limited, Hyderabad, India – FDA Inspections

Source: https://www.keypedia.com/companies/axis-clinicals-limited/2dfa100c-d6df-4e58-af35-865f3ea71ea2

> Inspection records and compliance data for AXIS Clinicals Limited in Hyderabad. 4 FDA inspections on record, last inspected September 20, 2024.

---

## Details

- Name: AXIS Clinicals Limited
- FEI Number: 3006649033
- Business Operations: CLINICAL BIOEQUIVALENCE OR BIOAVAILABILITY STUDY
- Address Line 1: 1-121/1, Survey Nos.66 (Part) & 67(Part, Gachibowli - Miyapur Rd, Serilingampalle (M)
- City: Hyderabad
- Country Name: India
- Address: 1-121/1, Survey Nos.66 (Part) & 67(Part, Gachibowli - Miyapur Rd, Serilingampalle (M), Hyderabad, India
- Country: India

## Related Documents

- [FDA Inspection 1253009 - AXIS Clinicals Limited - 2024-09-20](https://www.keypedia.com/records/fda_inspections/axis-clinicals-limited/680110f7-fd54-4427-9eef-bc56755c6667) — source: FDA, date: September 20, 2024
- [FDA Inspection 1253009 - AXIS Clinicals Limited - 2024-09-20](https://www.keypedia.com/records/fda_inspections/axis-clinicals-limited/739bad41-daa8-48b6-a2e2-17dd483c6124) — classification: No Action Indicated (NAI), source: FDA, date: September 20, 2024
- [FDA Inspection 1171571 - AXIS Clinicals Limited - 2022-04-28](https://www.keypedia.com/records/fda_inspections/axis-clinicals-limited/01065cb0-0eb2-4ef6-95ec-cf745319c00b) — classification: No Action Indicated (NAI), source: FDA, date: April 28, 2022
- [FDA Inspection 1073020 - AXIS Clinicals Limited - 2018-11-06](https://www.keypedia.com/records/fda_inspections/axis-clinicals-limited/264fbafc-9bf7-43c9-ad24-9da628955aca) — classification: No Action Indicated (NAI), source: FDA, date: November 6, 2018
- [FDA Inspection 1070426 - AXIS Clinicals Limited - 2018-08-30](https://www.keypedia.com/records/fda_inspections/axis-clinicals-limited/dd74cf01-5234-4a7e-8704-876c5834d448) — classification: No Action Indicated (NAI), source: FDA, date: August 30, 2018

## Related Companies

- [Dr. Ajit Bapurao Nalawade](https://www.keypedia.com/companies/dr-ajit-bapurao-nalawade/8f9ebcae-947e-4f2e-aeed-446b996de044)
- [MV Hospital and Research Centre](https://www.keypedia.com/companies/mv-hospital-and-research-centre/b32e386a-5c1d-4cd5-a610-7b4b73d54bf3)
- [VerGo Pharma Research Pvt., Ltd](https://www.keypedia.com/companies/vergo-pharma-research-pvt-ltd/d2de0251-dfa6-43c8-a086-06362372ce73)
- [Nitin Kulkarni, MBBS](https://www.keypedia.com/companies/nitin-kulkarni-mbbs/2923725d-630c-4e5a-b4d1-d3febb945668)
- [Srikara Hospitals](https://www.keypedia.com/companies/srikara-hospitals/b0d2b1d3-cfc9-4ddb-bfb0-6190a0f16ae7)
- [Regional Institute of Ophthalmology (RIO)](https://www.keypedia.com/companies/regional-institute-of-ophthalmology-rio/d541d286-b2f3-4c8e-89a2-0aedae5073ff)
- [Avon Organics Limited](https://www.keypedia.com/companies/avon-organics-limited/ae616e13-4822-480e-97a8-93aebc5ea0a6)
- [Erode Cancer Centre](https://www.keypedia.com/companies/erode-cancer-centre/8d952bcb-5a81-4637-9f8f-55b3c4c600d6)
- [Vivek Urekar, M.D.](https://www.keypedia.com/companies/vivek-urekar-md/bd82b68b-78e4-40ed-91e2-166950b09426)
- [Aniruddha G. Tembe, M.D.](https://www.keypedia.com/companies/aniruddha-g-tembe-md/27b6ce09-aadf-469b-afc8-b8cab234010b)